Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date | Reported DateTime | Company | Symbol | Insider Relationship | Shares Traded | Average Price | Total Amount | Shares Owned | Filing |
| 2025-05-21 Purchase | 2025-05-23 4:06 pm | Phathom Pharmaceuticals Inc. | PHAT | Topper James N Director | 3,780 | $3.8649 | $14,609 | 5,922,827 (Indirect Direct) | View |
| 2025-05-13 Purchase | 2025-05-15 4:17 pm | Phathom Pharmaceuticals Inc. | PHAT | Topper James N Director | 7,420 | $3.2968 | $24,462 | 5,919,047 (Indirect Direct) | View |
| 2025-05-09 Purchase | 2025-05-13 4:13 pm | Phathom Pharmaceuticals Inc. | PHAT | Topper James N Director | 48,203 | $3.1723 | $152,917 | 5,911,627 (Indirect Direct) | View |
| 2025-05-06 Purchase | 2025-05-08 5:27 pm | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 10,000 | $2.4985 | $24,985 | 95,500 (Direct) | View |
| 2025-04-07 Sale | 2025-04-08 5:01 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 3,678 | $4.5513 | $16,740 | 91,779 (Indirect Direct) | View |
| 2025-03-13 Purchase | 2025-03-17 4:27 pm | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 10,000 | $4.42 | $44,200 | 85,500 (Direct) | View |
| 2025-01-21 Sale | 2025-01-23 4:24 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 6,583 | $6.5883 | $43,371 | 95,457 (Indirect Direct) | View |
| 2025-01-21 Sale | 2025-01-23 4:21 pm | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 7,886 | $6.5885 | $51,957 | 1,022,669 (Indirect Direct) | View |
| 2025-01-21 Sale | 2025-01-23 4:19 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 19,109 | $6.5877 | $125,884 | 364,305 (Indirect Direct) | View |
| 2024-12-19 Sale | 2024-12-20 4:21 pm | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 1,118 | $8 | $8,944 | 1,028,582 (Indirect Direct) | View |
| 2024-12-19 Sale | 2024-12-20 4:20 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 1,291 | $8 | $10,328 | 100,067 (Indirect Direct) | View |
| 2024-12-13 Purchase | 2024-12-16 08:05 am | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 12,500 | $7.9267 | $99,084 | 57,000 (Direct) | View |
| 2024-12-13 Purchase | 2024-12-16 08:05 am | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 10,000 | $8.1248 | $81,248 | 75,500 (Direct) | View |
| 2024-07-15 Sale | 2024-07-17 2:52 pm | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 10,901 | $11.72 | $127,760 | 1,029,700 (Indirect Direct) | View |
| 2024-07-15 Sale | 2024-07-17 2:51 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 4,325 | $11.72 | $50,689 | 101,358 (Indirect Direct) | View |
| 2024-07-15 Sale | 2024-07-17 2:50 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 33,848 | $11.72 | $396,699 | 381,574 (Indirect Direct) | View |
| 2024-04-08 Sale | 2024-04-10 4:30 pm | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 3,435 | $11.1 | $38,129 | 97,174 (Indirect Direct) | View |
| 2024-03-22 Sale | 2024-03-26 4:05 pm | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 16,851 | $9.11 | $153,513 | 414,624 (Indirect Direct) | View |
| 2024-01-24 Sale | 2024-01-25 06:13 am | Phathom Pharmaceuticals Inc. | PHAT | TAKEDA PHARMACEUTICAL CO LTD 10% Owner | 3,703,703 | $8.1 | $29,999,994 | 3,755,583 (Direct) | View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date | Reported DateTime | Exercisable Expiration | Company | Symnbol | Insider Relationship | Shares Traded | Conversion Price | Shares Owned | Filing |
| 2025-05-19 Option Award | 2025-05-21 5:17 pm | N/A 2035-05-18 | Phathom Pharmaceuticals Inc. | PHAT | Breedlove Robert Charles Principal Accounting Officer | 33,000 | $0 | 33,000 (Direct) | View |
Ownership | 2025-05-06 4:59 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Breedlove Robert Charles Principal Accounting Officer | 0 | $0 | 111,442 (Direct) | View |
| 2025-04-16 Option Award | 2025-04-16 5:44 pm | N/A 2035-04-15 | Phathom Pharmaceuticals Inc. | PHAT | Schroeder Theodore R Director | 56,000 | $0 | 56,000 (Direct) | View |
Ownership | 2025-04-16 5:37 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Schroeder Theodore R Director | 0 | $0 | 0 (Direct) | View |
| 2025-04-03 Option Award | 2025-04-03 5:30 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 1,445,000 | $0 | 1,445,000 (Direct) | View |
Ownership | 2025-04-03 5:29 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Basta Steven L President and CEO | 0 | $0 | 0 (Direct) | View |
| 2024-09-10 Exercise | 2025-03-21 4:46 pm | 2024-05-25 2033-05-24 | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 7,500 | $0 | 100,500 (Direct) | View |
| 2024-09-10 Exercise | 2025-03-21 4:46 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 7,500 | $11.72 | 100,500 (Direct) | View |
| 2025-02-27 Option Award | 2025-03-03 5:16 pm | N/A 2035-02-26 | Phathom Pharmaceuticals Inc. | PHAT | Curran Terrie President and Chief Executive | 342,500 | $0 | 342,500 (Direct) | View |
| 2025-02-27 Option Award | 2025-03-03 5:15 pm | N/A 2035-02-26 | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 122,000 | $0 | 217,457 (Direct) | View |
| 2025-02-27 Option Award | 2025-03-03 5:13 pm | N/A 2035-02-26 | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 134,200 | $0 | 1,156,869 (Direct) | View |
| 2024-05-31 Option Award | 2024-05-31 6:37 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Henderson Molly CFO and CBO | 7,500 | $0 | 104,674 (Direct) | View |
| 2024-05-31 Option Award | 2024-05-31 6:34 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Nabulsi Azmi Chief Operating Officer | 7,500 | $0 | 1,038,846 (Direct) | View |
| 2024-05-29 Option Award | 2024-05-31 4:30 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 25,000 | $10.16 | 44,500 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:47 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Topper James N Director 10% Owner | 28,000 | $0 | 5,880,924 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:46 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Parikh Asit Director | 28,000 | $0 | 83,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:44 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | COLA MICHAEL F Director | 28,000 | $0 | 46,798 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:43 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | FIELDS HEIDI Director | 28,000 | $0 | 37,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:33 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | KARBE FRANK Director | 28,000 | $0 | 37,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:18 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Stenhouse Mark Director | 28,000 | $0 | 37,000 (Direct) | View |
| 2024-05-23 Option Award | 2024-05-24 7:14 pm | N/A 2034-05-22 | Phathom Pharmaceuticals Inc. | PHAT | Socks David A Director | 28,000 | $0 | 1,248,756 (Direct) | View |
Ownership | 2024-01-26 4:35 pm | N/A N/A | Phathom Pharmaceuticals Inc. | PHAT | Medicxi Ventures Management (Jersey) Ltd Medicxi Growth I GP Ltd Medicxi Growth I LP Medicxi Growth Co-Invest I LP Medicxi IV GP Ltd Medicxi IV LP Medicxi Co-Invest IV LP 10% Owner | 0 | $0 | 7,464,572 (Indirect) | View |